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Setting limits for exposure doses to prevent
adverse outcomes in humans is an old debate
in radioprotection (1). Various threshold
values have been proposed. Historically, the
ﬁrst permissible dose proposed was linked to
deterministic effects of ionizing radiation.
These values were around 500 mSv (50
rems). The threshold doses at which nonsto-
chastic effects appear were based on these
ﬁgures. They have not been modiﬁed to date
and represent the dose limitation levels for
isolated organs.
Given recommendations from the
National Council of Radiation Protection
(NCRP), in 1956, the International
Commission on Radiological Protection
(ICRP) adopted the proposed dose limits,
expressed as the following simple equation
for occupational exposure and assuming that
people under 18 are not occupationally
exposed: The limits for occupational dose
accumulated at various ages is the dose D =
5 (N – 18), where N is the age in years, and
D is expressed in rems (2).
The risk level for the population was
proposed to be one-tenth of the occupa-
tional risk, computed for 1 year (i.e., 0.5
rems/year) (2). It is therefore not only
stochastic effects that will dominate radio-
protection, but, more decisively, it is the
cumulative aspect of radiation risk, especially
for cancers.
The cumulative risk model allows one to
take into account all radiations, even the
very small ones for individuals and for a
group. The consequences of this new con-
cept had an enormous impact for the nuclear
energy production industry, for example,
which now faces great difﬁculties as a result
of this risk concept (3). 
With the ICRP 26 (4), the stochastic
(i.e., cancer) and gonadic risks became the
basis of radioprotection. Indeed, as the ﬁrst
data on cancers following the bombings of
Nagasaki and Hiroshima became available,
the ICRP (2) proposed the computation of
the total body equivalent dose on the basis of
a total cancer risk per organ, and a gonadic
risk, the sum of weighting factors being
equal to 1. 
This computation supposed that a) there
is no threshold level of risk at the level of
organs, b) there is a hierarchy of risk between
organs, c) there are two reference effects—
stochastic effects of fatal cancers and a com-
plementary genetic risk, and d) there is a
simple relation between risk and ionizing
radiation based on an “absolute risk model.”
A known quantity of exposure induces a
known quantity of effect, so a change in the
baseline incidence rate in nonexposed per-
sons does not affect the magnitude of
increase in risk in exposed subjects. But this
reasoning has been challenged over time.
Analysis of the Normative
Approach
Normative recommendations. Except for the
induction of leukemia and bone cancers, the
epidemiologic model to consider is a relative
risk model (5). A known quantity of exposure
modiﬁes the outcome by a certain multiplica-
tive effect. A change in the baseline incidence
thus affects the level of outcome difference.
This model has several consequences: On
one hand, assuming that the cancer rates
increase over time, this new model implies an
increased risk difference. On the other hand,
the relative risk model means that ionizing
radiation is a cofactor of cancers, which was
not necessarily the case for an absolute risk
model. Ionizing radiation may be considered
a component, which modiﬁes proportionally
a general risk, whereas it is the specific
appearance rate of the general risk that deter-
mines the noxious action of radiations. In
other words, it is the conjunction of several
elements that explains the effect of ionizing
radiation, among which is the background
rate of cancer for the corresponding organ.
Fundamental research. Carcinogenesis is
a complex phenomenon that includes multi-
ple steps, some of which are sequential (6).
This is consistent with the cofactors neces-
sary for carcinogenesis.
Mutations necessary for carcinogenesis
may be linked not only to the action of an
external mutagenic factor, but also to increas-
ing instability of the nucleus (e.g., mutating
phenotype due to the loss of p53) (7). The
indirect action of ionizing radiation is cur-
rently under intense scientiﬁc scrutiny. If the
action of ionizing radiation is indirect, this
will modify the relationship between expo-
sure and effect, reinforcing the cofactorial
aspect.
The initial lesion consists of DNA dou-
ble-strand breaks, stabilized quite rapidly
within 2 hr. Why does such a lesion induce
chromosome aberrations a few generations
later (8)? The process is not well understood.
The concept of an indirect action of ionizing
radiation on carcinogenesis is therefore rein-
forced. Kennedy and Little (9) showed more
than a decade ago the dissociation between
causes and effects in ionizing radiation.
Cancer transformation cannot be dissoci-
ated from apoptosis of the progeny of irradi-
ated cells (10): This occurs belatedly, around
the 12th cellular generation, following a
mechanism that is not yet understood that
includes antiapoptosis processes that stop
progressively according to a biologic apopto-
sis clock. Understanding the mechanisms of
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cer transformation (11).
Suprasensitivity to low doses underlies
the hypothesis of supralinearity between
exposure and effects at the same dose, and
reflects the effect of cellular adaptability to
recurrent radiations (12–15). In addition,
this adaptability combines with weaknesses
in the defense mechanisms of the nucleus
against other genotoxic elements (16). This
is the price organisms pay for adaptation.
Research also focuses on nuclear instabil-
ity before cancer transformation. We know
about instability after the loss of control of
the p53 system. The idea of nuclear instabil-
ity goes beyond this and proposes an early
generalization of this instability: Instability
would be the cause, not the effect, of genetic
modifications necessary to cellular transfor-
mation and would be expressed progressively
through increasing cellular division (17). But
it may also be expressed itself along with cel-
lular aging (18).
Another emerging notion is that of indi-
rect genetic effects on cellular cytoplasm, or
even on the cytoplasm of neighbor cells. The
genotoxic target of ionizing radiation is
therefore larger than the genome itself (19).
Epidemiology. Stochastic effects are
observed during exposure at higher doses of
ionizing radiation than those encountered in
a normal environment. Indeed, from single
or cumulated doses above 250 mSv, observa-
tions are rather consistent. In contrast,
observations of effects from lower radiation
levels are surprisingly heterogeneous and
contradictory. 
An interesting example is the disparity of
ﬁndings within a Canadian study of the risk
of breast cancer among women irradiated by
fluoroscopies during the treatment of pul-
monary tuberculosis (20). The results of all
provinces are consistent among each other,
except Nova Scotia, which shows the most
important risk despite similar quantities of
irradiation (relative risks per Gray are, respec-
tively, 1.20 and 3.03). The difference
between Nova Scotia and other provinces has
not been explained. One hypothesis might be
the difference due to a higher dose delivery
rate during examinations in Nova Scotia. 
Debates exist about threshold values and
the relationship between exposure and sto-
chastic effects (21). One point of view is that
the stochastic risk is likely to have a thresh-
old level, which would be between 100 and
250 mSv (22). 
Another is that the stochastic risk has no
threshold level. The relationship may be
supralinear (increased effects at low doses); it
may be linear (23); or it may be quadratic
(minimized effects at low doses) (24). 
Current recommendations propose stan-
dards that account for a linear conservative
risk without threshold value, together with a
stochastic model computed on a quadratic
basis using the dose/dose-rate effectiveness
factor relationship (DDREF) = 2 below 0.2
Gy (i.e., a proportional decrease from the lin-
ear extrapolation without threshold value
computed at high doses) (25). But the rela-
tionship between very low exposure and effect
for residential radon is controversial (26). In
this respect, the controversy between the eco-
logic study of Cohen (27) and case–control
studies is interesting. Cohen (27) explains the
discrepancy between these studies as proof of
the absence of linearity between exposure and
effect in very low radon exposures. On the
other hand, Lubin and Boice (28) think that
the discrepancy is caused by the “epidemio-
logic fallacy” (29). Controversies over the
weaknesses of ecologic studies have been dis-
cussed by many authors (30,31). Other
cofactors may explain the discrepancy. For
example, smoking is an important cofactor
(32). The effect is neither additive nor multi-
plicative, but somewhere in between.
Smoking limits the risk of radon versus non-
smoking habit [relative risk (RR)no smoking = 
1 + 0.0103 working-level month (WLM);
RRsmoking = 1 + 0.0034 WLM]. Other expla-
nations have been proposed, such as latitude
or rural/urban status (33,34). 
Discussion
Rothman (35) deﬁnes the cause of a disease
“as an event, condition, or characteristic that
plays an essential role in producing an occur-
rence of the disease” (p. 11). He also argues
that the appearance of a disease is linked to a
process involving several components, each of
them being necessary but not sufficient to
cause disease. When we examine the complex,
sequential process of cancer, this hypothesis is
obviously more plausible than the unique
causality determining a unique effect.
Causality seems therefore to be multiple. In
each sufﬁcient causal group, there would be a
number of necessary but not sufﬁcient com-
ponents, except in the case of a causal group
that comprises a single component (Figure 1).
If one component is missing, the causality
disappears. In this approach, the less frequent
component will be the limiting factor of
causality. Given relative scarcity of this com-
ponent compared to others, it will be a deter-
mining factor. From this point of view, the
cumulative importance attributed to all the
necessary factors of causality can obviously
exceed 100%. The paradigm of this approach
lies in the fact that the component that
appears to be the most noxious and the most
determining is actually the least important
because of its scarcity in the causal group.
Rothman (35) proposes that “each con-
stellation of component causes is minimally
sufficient (i.e., there are no redundant or
extraneous component causes) to produce
the disease. Component causes may play a
role in one, two or three causal mechanisms.
… Thus, the apparent strength of a cause is
determined by the relative prevalence of
component causes. A rare factor becomes a
strong cause if its complementary causes are
common” (p. 12). The rare factor is a critical
component. In contrast, a frequent factor
becomes of minimal effect if its complemen-
tary causes are infrequent.
Difficulties lie in the exposure and risk
assessment of all contributing toxic sub-
stances of environmental concern (36).
When the Rothman model is applied to the
risk induced by ionizing radiation, some
inconsistencies or controversies in the obser-
vations may be better understood. The same
may be said of the application of fundamen-
tal research. Difﬁculties may be resolved by
seeking other components of different causal
groups in which ionizing radiation is one of
the factors. Risk assessment should take into
account all the factors, provided that the
importance of each individual factor cannot
be assumed. In other words, the problems
will not be resolved completely by consider-
ing only the ionizing radiation.
Examples
In a case–control study, in which Stewart et
al. (37) observed an increase of leukemia in
children exposed in utero to simple X rays, a
controversy arose immediately because the
dose required for risk of leukemia was
decreased by at least an order of magnitude
(10 times less, dose around 10 mSv) (38).
Surprising in this debate was the position of
MacMahon (39), who found an effect of the
same size in a cohort study of 700,000 chil-
dren, but refused to admit the causality,
arguing first the presence of an unknown
confounding factor (40). MacMahon (41)
stated that three observations seemed incom-
patible with the results of Stewart: ﬁrst, the
observed cancer risks of the children irradi-
ated in utero at the time of the atomic
bombs; second, a significant difference
between the absolute risk coefficients for
infants exposed prenatally and those exposed
after birth; and third, the ﬁnding of an equiv-
alent increase in solid cancers, which seemed
to him uncharacteristic. In fact, differences
seem to exist between childhood and adult
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Figure 1. Causal groups. A, B, C, and D are neces-
sary but not sufficient components, except for
Group IV, where A is a sufficient component. 
Adapted from Rothman (35).
A
B C
C
A
B
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B A
Group I Group II Group III Group IV
Dcancer sensibility, cancer latency, types of
tumors, and period of cancer sensibility dur-
ing pregnancy. There is also limited infor-
mation about cancer risk for children
irradiated early in postnatal life (42). Doll
and Wakeford (43) and Boice and Miller
(44) studied the elements in favor of causal-
ity and related uncertainties in the case of
leukemia in children exposed in utero, with
contrary conclusions about a causal epidemi-
ologic association between prenatal irradia-
tion and childhood leukemia and cancer.
The finding in the nuclear industry, at
Oak Ridge National Laboratory (45), of
increased mortality due to leukemia among
the workers was strongly debated (46). The
results at the Oak Ridge National Laboratory
led to investigations of an unknown con-
founding factor (47). A better appraisal of
the healthy worker effect and the observation
of a higher susceptibility to radiation with
age over 45 have been proposed to explain
certain results of the Oak Ridge study (38).
Studies about occupational radiation expo-
sure in Canada show similar results (48)
(with an estimated excess RR of 3% per 10
mSv), whereas other observations failed to
show any harmful effect. 
Gardner et al.’s (49) hypothesis that
childhood leukemia is attributable to the
father’s low occupational exposure to radia-
tion was the center of an intense controversy
(42). Geographic disparities (50) together
with confounding factors (51) were proposed
as explanations for the cluster observed.
The cluster found in Berlin showing an
increase in the rate of Down syndrome in
children of mothers exposed to the Chernobyl
nuclear accident was explained by an iodine
deﬁciency in these populations (52).
The study of susceptible and fragile pop-
ulations is essential in this respect because the
genetic aspect is obviously one of the compo-
nents of the causal groups. Persons with a
heterozygous gene for ataxia telangectasia
(53), or carrying a gene for Li-Fraumeni syn-
drome (54) are examples of susceptible popu-
lations. Lavin et al. (55) found higher
sensitive subgroups of breast cancer patients. 
Analyses of studies of the survivors of
nuclear bombings are not always consistent
(56–58). It is important to note that the con-
troversy occurs because of heterogeneity of
effects in a possibly biased cohort compared
to exceptionally healthy persons. Stewart (59)
found a selection bias in the Life Span Study
Cohort. A susceptibility difference to radia-
tion cancer effects in the exposed population
may be explained by age (cutoff at ± 50 years
of age) and by amounts of irradiation (thresh-
old for excessive marrow damage). Thus,
atomic bomb survivors may not be represen-
tative of populations exposed to radiation by
other means (38): “As a result of these biases,
atomic bomb data are not a reliable source of
cancer risk coefﬁcients, but they can still be
used to study factors with immune system
associations” (p. 96). 
New concepts regarding the oxidative
cellular stress induced by irradiation, which
produces free radicals, involve oxidative stress
in complex mechanisms, which is not only
linked to the genetic proﬁle, but is also com-
mon to other toxicologic mechanisms. In the
same way, the production of transmissible
cell-to-cell effects, between hit and nonhit
cells (bystander effects), and a transmissible
effect of an instability phenotype reinforce
the theory of necessary but not sufﬁcient nor
unique components of a causal group and the
necessary synergy with other toxic, physio-
logic, or genetic components (19).
Conclusion
The hypothesis of a causal group with neces-
sary but not sufficient components implies
that the hypothesis of a risk without thresh-
old value should be maintained until all the
components of the causal groups are deﬁned.
Because, in principle, it will never be possi-
ble to know all the causal groups and their
composition, the hypothesis of no threshold
value should be maintained. 
It is, moreover, possible that among all
the causal groups including the component
of ionizing radiation, there is at least one
group that includes only ionizing radiation.
The supralinear, linear, quadratic, or
other relationship is linked not necessarily to
the irradiation itself, but to the combination
of various components. If the existence of
these components is admitted, one must
allow reasonable pessimistic hypotheses
because uncertainties necessarily remain in
the composition of the causal group.
Eliminating one of the components will
lead to the elimination of causal group(s)
where this component is present, and there-
fore a decrease of the global risk associated
with the other components of these causal
groups may occur.
Research must focus on components
other than ionizing radiation, because these
factors might be equally important (not
restrictive of the effect). It may be possible to
operate on these factors to make them
become restrictive of the effect. This is
reﬂected by environmental cancer prevention.
The hypothesis of causal groups implies
that we must investigate not only the reason
for an effect linked to exposure to ionizing
radiation, but also the reason for a lack of
effect after exposure. In this particular situa-
tion, a (partial) eliminated (critical) compo-
nent must be investigated. This is implicit in
the hypothesis that a different restrictive
component is included in the same causal
group as ionizing radiation.
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